Close

BIND Therapeutics (BIND), Amgen (AMGN) Complete Collaboration

July 2, 2014 4:03 PM EDT Send to a Friend
BIND Therapeutics, Inc. (NASDAQ: BIND) announced the completion of its collaborative research program with Amgen Inc. (Nasdaq: AMGN) originally entered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login